

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 5.34407227 |
| 2 | central nervous system myelination (GO:0022010) | 5.34407227 |
| 3 | response to pheromone (GO:0019236) | 4.26234671 |
| 4 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.86157773 |
| 5 | myelination (GO:0042552) | 3.82478791 |
| 6 | axon ensheathment (GO:0008366) | 3.81116760 |
| 7 | ensheathment of neurons (GO:0007272) | 3.81116760 |
| 8 | behavioral response to nicotine (GO:0035095) | 3.79082744 |
| 9 | fatty acid elongation (GO:0030497) | 3.70365416 |
| 10 | regulation of mesoderm development (GO:2000380) | 3.47343567 |
| 11 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.44496892 |
| 12 | somite development (GO:0061053) | 3.36034050 |
| 13 | apical protein localization (GO:0045176) | 3.30666951 |
| 14 | protein polyglutamylation (GO:0018095) | 3.27228023 |
| 15 | asymmetric protein localization (GO:0008105) | 3.26778004 |
| 16 | establishment of mitochondrion localization (GO:0051654) | 3.24879905 |
| 17 | epithelial cilium movement (GO:0003351) | 3.24673664 |
| 18 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.23433471 |
| 19 | kidney morphogenesis (GO:0060993) | 3.23298887 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 3.22749613 |
| 21 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.18866058 |
| 22 | negative regulation of neurotransmitter transport (GO:0051589) | 3.17799237 |
| 23 | regulation of acrosome reaction (GO:0060046) | 3.17429326 |
| 24 | atrial cardiac muscle cell action potential (GO:0086014) | 3.14695083 |
| 25 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.14175182 |
| 26 | regulation of action potential (GO:0098900) | 3.05664513 |
| 27 | axoneme assembly (GO:0035082) | 3.04854387 |
| 28 | eye photoreceptor cell differentiation (GO:0001754) | 3.04653967 |
| 29 | photoreceptor cell differentiation (GO:0046530) | 3.04653967 |
| 30 | dendrite morphogenesis (GO:0048813) | 3.00151957 |
| 31 | myelination in peripheral nervous system (GO:0022011) | 2.98598468 |
| 32 | peripheral nervous system axon ensheathment (GO:0032292) | 2.98598468 |
| 33 | layer formation in cerebral cortex (GO:0021819) | 2.98428014 |
| 34 | cornea development in camera-type eye (GO:0061303) | 2.97195755 |
| 35 | positive regulation of action potential (GO:0045760) | 2.95730795 |
| 36 | retinal cone cell development (GO:0046549) | 2.92758070 |
| 37 | presynaptic membrane assembly (GO:0097105) | 2.92147290 |
| 38 | negative regulation of protein localization to cell surface (GO:2000009) | 2.84474035 |
| 39 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.82019149 |
| 40 | glycerophospholipid catabolic process (GO:0046475) | 2.80920364 |
| 41 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.79060921 |
| 42 | detection of light stimulus involved in visual perception (GO:0050908) | 2.79060921 |
| 43 | oligodendrocyte differentiation (GO:0048709) | 2.77702950 |
| 44 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.76678648 |
| 45 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.75814738 |
| 46 | presynaptic membrane organization (GO:0097090) | 2.75627066 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 2.75188414 |
| 48 | retinal ganglion cell axon guidance (GO:0031290) | 2.73360574 |
| 49 | nerve growth factor signaling pathway (GO:0038180) | 2.71825026 |
| 50 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.71783293 |
| 51 | neuron recognition (GO:0008038) | 2.71225156 |
| 52 | negative regulation of dendrite development (GO:2000171) | 2.70291589 |
| 53 | keratinocyte development (GO:0003334) | 2.70170792 |
| 54 | inositol phosphate catabolic process (GO:0071545) | 2.67432068 |
| 55 | transmission of nerve impulse (GO:0019226) | 2.67359449 |
| 56 | startle response (GO:0001964) | 2.64325343 |
| 57 | protein localization to cilium (GO:0061512) | 2.63946473 |
| 58 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.63257936 |
| 59 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.63091423 |
| 60 | gamma-aminobutyric acid transport (GO:0015812) | 2.62317983 |
| 61 | behavioral response to ethanol (GO:0048149) | 2.62177362 |
| 62 | cilium morphogenesis (GO:0060271) | 2.62144056 |
| 63 | cerebellar granule cell differentiation (GO:0021707) | 2.62032349 |
| 64 | L-fucose metabolic process (GO:0042354) | 2.61825872 |
| 65 | L-fucose catabolic process (GO:0042355) | 2.61825872 |
| 66 | fucose catabolic process (GO:0019317) | 2.61825872 |
| 67 | prostate gland growth (GO:0060736) | 2.61787107 |
| 68 | intraciliary transport (GO:0042073) | 2.60807421 |
| 69 | virion attachment to host cell (GO:0019062) | 2.60257591 |
| 70 | adhesion of symbiont to host cell (GO:0044650) | 2.60257591 |
| 71 | cilium movement (GO:0003341) | 2.59890788 |
| 72 | neural tube formation (GO:0001841) | 2.59282948 |
| 73 | nucleobase catabolic process (GO:0046113) | 2.58630725 |
| 74 | astrocyte development (GO:0014002) | 2.58028741 |
| 75 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.56941647 |
| 76 | neuronal action potential (GO:0019228) | 2.56565589 |
| 77 | action potential (GO:0001508) | 2.55463082 |
| 78 | nonmotile primary cilium assembly (GO:0035058) | 2.55391202 |
| 79 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.55033448 |
| 80 | photoreceptor cell development (GO:0042461) | 2.54752104 |
| 81 | regulation of meiosis I (GO:0060631) | 2.54663484 |
| 82 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.52495147 |
| 83 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.51944395 |
| 84 | cell migration in hindbrain (GO:0021535) | 2.50374204 |
| 85 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.50313048 |
| 86 | creatine metabolic process (GO:0006600) | 2.49800734 |
| 87 | response to methylmercury (GO:0051597) | 2.49185167 |
| 88 | cellular response to epinephrine stimulus (GO:0071872) | 2.49001419 |
| 89 | auditory behavior (GO:0031223) | 2.48766803 |
| 90 | myelin maintenance (GO:0043217) | 2.48379741 |
| 91 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.48003215 |
| 92 | regulation of telomere maintenance (GO:0032204) | 2.47157668 |
| 93 | glutamate receptor signaling pathway (GO:0007215) | 2.47045903 |
| 94 | L-phenylalanine catabolic process (GO:0006559) | 2.46983101 |
| 95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.46983101 |
| 96 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.45915291 |
| 97 | cell communication involved in cardiac conduction (GO:0086065) | 2.45859688 |
| 98 | axonal fasciculation (GO:0007413) | 2.45831430 |
| 99 | spinal cord development (GO:0021510) | 2.45432646 |
| 100 | platelet dense granule organization (GO:0060155) | 2.44329830 |
| 101 | sympathetic nervous system development (GO:0048485) | 2.43682178 |
| 102 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.43413411 |
| 103 | mitochondrion transport along microtubule (GO:0047497) | 2.43413411 |
| 104 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.42469444 |
| 105 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.41781743 |
| 106 | membrane tubulation (GO:0097320) | 2.41654338 |
| 107 | synaptic vesicle maturation (GO:0016188) | 2.41058628 |
| 108 | multicellular organismal signaling (GO:0035637) | 2.40934033 |
| 109 | indolalkylamine metabolic process (GO:0006586) | 2.40818139 |
| 110 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.40733946 |
| 111 | eye photoreceptor cell development (GO:0042462) | 2.39328223 |
| 112 | DNA deamination (GO:0045006) | 2.39032117 |
| 113 | reflex (GO:0060004) | 2.38844430 |
| 114 | glycosphingolipid biosynthetic process (GO:0006688) | 2.38660638 |
| 115 | pancreas development (GO:0031016) | 2.38395224 |
| 116 | synapse assembly (GO:0007416) | 2.38393871 |
| 117 | spinal cord motor neuron differentiation (GO:0021522) | 2.37408036 |
| 118 | vocalization behavior (GO:0071625) | 2.37262488 |
| 119 | protein localization to endosome (GO:0036010) | 2.36806576 |
| 120 | polyol catabolic process (GO:0046174) | 2.35743467 |
| 121 | mechanosensory behavior (GO:0007638) | 2.35445144 |
| 122 | regulation of cilium movement (GO:0003352) | 2.35391970 |
| 123 | cilium organization (GO:0044782) | 2.35039436 |
| 124 | rhodopsin mediated signaling pathway (GO:0016056) | 2.34301002 |
| 125 | piRNA metabolic process (GO:0034587) | 2.34129475 |
| 126 | hindbrain development (GO:0030902) | 2.33415962 |
| 127 | DNA double-strand break processing (GO:0000729) | 2.33175442 |
| 128 | import into cell (GO:0098657) | 2.32751891 |
| 129 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.32277996 |
| 130 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.31901501 |
| 131 | dentate gyrus development (GO:0021542) | 2.31783567 |
| 132 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.31724453 |
| 133 | embryonic epithelial tube formation (GO:0001838) | 2.31579188 |
| 134 | endoderm formation (GO:0001706) | 2.31213528 |
| 135 | postsynaptic membrane organization (GO:0001941) | 2.30878665 |
| 136 | neurotransmitter catabolic process (GO:0042135) | 2.30494507 |
| 137 | neuron-neuron synaptic transmission (GO:0007270) | 2.30228854 |
| 138 | neuronal ion channel clustering (GO:0045161) | 2.28990651 |
| 139 | membrane assembly (GO:0071709) | 2.28591156 |
| 140 | cilium assembly (GO:0042384) | 2.28348865 |
| 141 | synaptic transmission, cholinergic (GO:0007271) | 2.28185243 |
| 142 | negative regulation of axon guidance (GO:1902668) | 2.27804238 |
| 143 | positive regulation of glomerulus development (GO:0090193) | 2.27094050 |
| 144 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.26758974 |
| 145 | glutamate secretion (GO:0014047) | 2.26610354 |
| 146 | negative regulation of axonogenesis (GO:0050771) | 2.26528593 |
| 147 | cellular response to catecholamine stimulus (GO:0071870) | 2.26355847 |
| 148 | cellular response to monoamine stimulus (GO:0071868) | 2.26355847 |
| 149 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.25623595 |
| 150 | neuronal action potential propagation (GO:0019227) | 2.25391595 |
| 151 | regulation of glucokinase activity (GO:0033131) | 2.24916797 |
| 152 | regulation of hexokinase activity (GO:1903299) | 2.24916797 |
| 153 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.24321370 |
| 154 | response to epinephrine (GO:0071871) | 2.24305185 |
| 155 | neuron fate determination (GO:0048664) | 2.24072891 |
| 156 | adult walking behavior (GO:0007628) | 2.23484921 |
| 157 | cholesterol biosynthetic process (GO:0006695) | 2.23471193 |
| 158 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.22837567 |
| 159 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.18926616 |
| 160 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.18568607 |
| 161 | substantia nigra development (GO:0021762) | 2.18195146 |
| 162 | organelle transport along microtubule (GO:0072384) | 2.17850585 |
| 163 | protein targeting to Golgi (GO:0000042) | 2.16041149 |
| 164 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.15937218 |
| 165 | limb bud formation (GO:0060174) | 2.15159524 |
| 166 | camera-type eye morphogenesis (GO:0048593) | 2.13475475 |
| 167 | locomotory exploration behavior (GO:0035641) | 2.13370340 |
| 168 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.12161934 |
| 169 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.11247381 |
| 170 | regulation of collateral sprouting (GO:0048670) | 2.11073783 |
| 171 | neuromuscular junction development (GO:0007528) | 2.10425542 |
| 172 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.09788640 |
| 173 | regulation of cardioblast differentiation (GO:0051890) | 2.08829708 |
| 174 | cellular ketone body metabolic process (GO:0046950) | 2.08139455 |
| 175 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.07635952 |
| 176 | response to nerve growth factor (GO:1990089) | 2.07635952 |
| 177 | response to catecholamine (GO:0071869) | 2.07421020 |
| 178 | response to monoamine (GO:0071867) | 2.07421020 |
| 179 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.07151527 |
| 180 | negative regulation of axon extension (GO:0030517) | 2.05813948 |
| 181 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 2.05663483 |
| 182 | establishment of protein localization to Golgi (GO:0072600) | 2.05425729 |
| 183 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.05382574 |
| 184 | regulation of cell communication by electrical coupling (GO:0010649) | 2.04757335 |
| 185 | positive regulation of potassium ion transport (GO:0043268) | 2.04537449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.83317683 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.79157976 |
| 3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.70884738 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.33569408 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.22888803 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.21149575 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.18676193 |
| 8 | FUS_26573619_Chip-Seq_HEK293_Human | 2.17406201 |
| 9 | EWS_26573619_Chip-Seq_HEK293_Human | 2.12803593 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.04019137 |
| 11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.03915180 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.94929992 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.94929992 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.92158562 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.91458716 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.89495711 |
| 17 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.87893962 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.85190510 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.83170668 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.80605837 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.74948954 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.74813020 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.74299503 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73534051 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.72479046 |
| 26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.72177255 |
| 27 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.69723837 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.66827881 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.65137918 |
| 30 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.63384465 |
| 31 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.62942223 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.62556387 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.60472359 |
| 34 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.57850532 |
| 35 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.55318886 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.55148776 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.55120865 |
| 38 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53707198 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.52701879 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49159373 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48093030 |
| 42 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.47926920 |
| 43 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.46699190 |
| 44 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.46578400 |
| 45 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.46123405 |
| 46 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.45108236 |
| 47 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.45108236 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.42691480 |
| 49 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.42110101 |
| 50 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40723938 |
| 51 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.38314148 |
| 52 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.37897428 |
| 53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.36383534 |
| 54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.35087126 |
| 55 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33908291 |
| 56 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.33906494 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33620111 |
| 58 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32752513 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31822540 |
| 60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30360230 |
| 61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29677287 |
| 62 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29496289 |
| 63 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.29496289 |
| 64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29096243 |
| 65 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28647104 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.28050051 |
| 67 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.27467432 |
| 68 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.26814231 |
| 69 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.25822066 |
| 70 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.24686348 |
| 71 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.23972366 |
| 72 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23815076 |
| 73 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23815076 |
| 74 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23578453 |
| 75 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.23521140 |
| 76 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23086957 |
| 77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23010188 |
| 78 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.22274513 |
| 79 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.22005648 |
| 80 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21752785 |
| 81 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20768684 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20150183 |
| 83 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.19790850 |
| 84 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19747617 |
| 85 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19182332 |
| 86 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18496649 |
| 87 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.18106181 |
| 88 | P300_19829295_ChIP-Seq_ESCs_Human | 1.17943467 |
| 89 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.16960065 |
| 90 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16438254 |
| 91 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15873529 |
| 92 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.14169392 |
| 93 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13728753 |
| 94 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11929236 |
| 95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11385535 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10485444 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10485444 |
| 98 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.10070409 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09949221 |
| 100 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09879378 |
| 101 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09787076 |
| 102 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09749027 |
| 103 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08659689 |
| 104 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08045557 |
| 105 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08014565 |
| 106 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.07497556 |
| 107 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.06837242 |
| 108 | VDR_22108803_ChIP-Seq_LS180_Human | 1.06650542 |
| 109 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.06587960 |
| 110 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.06340866 |
| 111 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06326175 |
| 112 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05908212 |
| 113 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.05608638 |
| 114 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04987608 |
| 115 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03990815 |
| 116 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.03814026 |
| 117 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03392309 |
| 118 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03294597 |
| 119 | JUN_21703547_ChIP-Seq_K562_Human | 1.02391987 |
| 120 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01609470 |
| 121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00382734 |
| 122 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.00214710 |
| 123 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00162510 |
| 124 | AR_19668381_ChIP-Seq_PC3_Human | 0.99807215 |
| 125 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99478235 |
| 126 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99296040 |
| 127 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99166754 |
| 128 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99143439 |
| 129 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99030678 |
| 130 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98701414 |
| 131 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98519386 |
| 132 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.98391753 |
| 133 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98133186 |
| 134 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98114376 |
| 135 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97999384 |
| 136 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97525133 |
| 137 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96924571 |
| 138 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96878154 |
| 139 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.96498624 |
| 140 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.95359606 |
| 141 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.95281421 |
| 142 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93023044 |
| 143 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92662351 |
| 144 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91543275 |
| 145 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91484393 |
| 146 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91352789 |
| 147 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90916058 |
| 148 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.90807916 |
| 149 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89453075 |
| 150 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.89435279 |
| 151 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89267806 |
| 152 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88206249 |
| 153 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.87920622 |
| 154 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87416969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004270_analgesia | 3.61461578 |
| 2 | MP0002102_abnormal_ear_morphology | 3.51731799 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.02750082 |
| 4 | MP0000920_abnormal_myelination | 2.91914799 |
| 5 | MP0003787_abnormal_imprinting | 2.61823193 |
| 6 | MP0003880_abnormal_central_pattern | 2.61817381 |
| 7 | MP0008877_abnormal_DNA_methylation | 2.60301610 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.52414196 |
| 9 | MP0001984_abnormal_olfaction | 2.47228381 |
| 10 | MP0003329_amyloid_beta_deposits | 2.36572628 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.26049348 |
| 12 | MP0003690_abnormal_glial_cell | 2.22100472 |
| 13 | MP0000778_abnormal_nervous_system | 2.14988411 |
| 14 | MP0004885_abnormal_endolymph | 2.14811711 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.10515188 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.09564258 |
| 17 | MP0001486_abnormal_startle_reflex | 2.03345653 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 1.94901703 |
| 19 | MP0002736_abnormal_nociception_after | 1.93330957 |
| 20 | MP0006072_abnormal_retinal_apoptosis | 1.91940468 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 1.90844192 |
| 22 | MP0003890_abnormal_embryonic-extraembry | 1.87541039 |
| 23 | MP0006292_abnormal_olfactory_placode | 1.86290372 |
| 24 | MP0002064_seizures | 1.78794139 |
| 25 | MP0002272_abnormal_nervous_system | 1.75744960 |
| 26 | MP0003122_maternal_imprinting | 1.72040112 |
| 27 | MP0009046_muscle_twitch | 1.71534271 |
| 28 | MP0003634_abnormal_glial_cell | 1.71458098 |
| 29 | MP0005253_abnormal_eye_physiology | 1.70407610 |
| 30 | MP0003121_genomic_imprinting | 1.68023546 |
| 31 | MP0005499_abnormal_olfactory_system | 1.64661000 |
| 32 | MP0005394_taste/olfaction_phenotype | 1.64661000 |
| 33 | MP0002139_abnormal_hepatobiliary_system | 1.64309815 |
| 34 | MP0003119_abnormal_digestive_system | 1.61455546 |
| 35 | MP0002063_abnormal_learning/memory/cond | 1.61368314 |
| 36 | MP0009745_abnormal_behavioral_response | 1.61158092 |
| 37 | MP0008789_abnormal_olfactory_epithelium | 1.60424017 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.57719599 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.57482448 |
| 40 | MP0000631_abnormal_neuroendocrine_gland | 1.57323418 |
| 41 | MP0000579_abnormal_nail_morphology | 1.53691175 |
| 42 | MP0002638_abnormal_pupillary_reflex | 1.50003563 |
| 43 | MP0004742_abnormal_vestibular_system | 1.48863317 |
| 44 | MP0002229_neurodegeneration | 1.46579597 |
| 45 | MP0000427_abnormal_hair_cycle | 1.44463490 |
| 46 | MP0003137_abnormal_impulse_conducting | 1.43919108 |
| 47 | MP0004036_abnormal_muscle_relaxation | 1.42577052 |
| 48 | MP0005423_abnormal_somatic_nervous | 1.41414531 |
| 49 | MP0000751_myopathy | 1.41350524 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.40964583 |
| 51 | MP0004924_abnormal_behavior | 1.40964583 |
| 52 | MP0001299_abnormal_eye_distance/ | 1.40614219 |
| 53 | MP0000955_abnormal_spinal_cord | 1.38791393 |
| 54 | MP0004215_abnormal_myocardial_fiber | 1.38085815 |
| 55 | MP0002572_abnormal_emotion/affect_behav | 1.35169817 |
| 56 | MP0005360_urolithiasis | 1.34346287 |
| 57 | MP0004084_abnormal_cardiac_muscle | 1.32231671 |
| 58 | MP0010678_abnormal_skin_adnexa | 1.31576585 |
| 59 | MP0005085_abnormal_gallbladder_physiolo | 1.31575490 |
| 60 | MP0002733_abnormal_thermal_nociception | 1.30760108 |
| 61 | MP0002234_abnormal_pharynx_morphology | 1.30060660 |
| 62 | MP0001485_abnormal_pinna_reflex | 1.28793243 |
| 63 | MP0003252_abnormal_bile_duct | 1.27569774 |
| 64 | MP0008872_abnormal_physiological_respon | 1.26863886 |
| 65 | MP0004085_abnormal_heartbeat | 1.26779684 |
| 66 | MP0002882_abnormal_neuron_morphology | 1.26728021 |
| 67 | MP0005645_abnormal_hypothalamus_physiol | 1.26675686 |
| 68 | MP0000372_irregular_coat_pigmentation | 1.26414581 |
| 69 | MP0005646_abnormal_pituitary_gland | 1.25213168 |
| 70 | MP0003632_abnormal_nervous_system | 1.24856102 |
| 71 | MP0005451_abnormal_body_composition | 1.24802821 |
| 72 | MP0001348_abnormal_lacrimal_gland | 1.24623570 |
| 73 | MP0003283_abnormal_digestive_organ | 1.24300535 |
| 74 | MP0002938_white_spotting | 1.23757358 |
| 75 | MP0002751_abnormal_autonomic_nervous | 1.22803065 |
| 76 | MP0000516_abnormal_urinary_system | 1.21045769 |
| 77 | MP0005367_renal/urinary_system_phenotyp | 1.21045769 |
| 78 | MP0000604_amyloidosis | 1.20932780 |
| 79 | MP0004145_abnormal_muscle_electrophysio | 1.20806069 |
| 80 | MP0004133_heterotaxia | 1.19582766 |
| 81 | MP0004858_abnormal_nervous_system | 1.16379462 |
| 82 | MP0000462_abnormal_digestive_system | 1.14905452 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 1.14572579 |
| 84 | MP0001188_hyperpigmentation | 1.13903929 |
| 85 | MP0003011_delayed_dark_adaptation | 1.12775182 |
| 86 | MP0008775_abnormal_heart_ventricle | 1.11980418 |
| 87 | MP0001529_abnormal_vocalization | 1.11879026 |
| 88 | MP0001346_abnormal_lacrimal_gland | 1.11308905 |
| 89 | MP0002972_abnormal_cardiac_muscle | 1.11051204 |
| 90 | MP0002067_abnormal_sensory_capabilities | 1.11048322 |
| 91 | MP0004043_abnormal_pH_regulation | 1.10310960 |
| 92 | MP0005330_cardiomyopathy | 1.09428531 |
| 93 | MP0002735_abnormal_chemical_nociception | 1.09366445 |
| 94 | MP0003718_maternal_effect | 1.08905377 |
| 95 | MP0002160_abnormal_reproductive_system | 1.08278609 |
| 96 | MP0000383_abnormal_hair_follicle | 1.06736189 |
| 97 | MP0001970_abnormal_pain_threshold | 1.06444265 |
| 98 | MP0002163_abnormal_gland_morphology | 1.05656468 |
| 99 | MP0003195_calcinosis | 1.05608290 |
| 100 | MP0002184_abnormal_innervation | 1.05467319 |
| 101 | MP0010234_abnormal_vibrissa_follicle | 1.05237801 |
| 102 | MP0005171_absent_coat_pigmentation | 1.04231554 |
| 103 | MP0002066_abnormal_motor_capabilities/c | 1.03164523 |
| 104 | MP0002822_catalepsy | 1.01415147 |
| 105 | MP0005620_abnormal_muscle_contractility | 1.00928598 |
| 106 | MP0001502_abnormal_circadian_rhythm | 1.00913623 |
| 107 | MP0001905_abnormal_dopamine_level | 1.00442109 |
| 108 | MP0000647_abnormal_sebaceous_gland | 1.00403362 |
| 109 | MP0008569_lethality_at_weaning | 0.99785817 |
| 110 | MP0003646_muscle_fatigue | 0.99565261 |
| 111 | MP0004130_abnormal_muscle_cell | 0.98705909 |
| 112 | MP0002653_abnormal_ependyma_morphology | 0.97389565 |
| 113 | MP0008058_abnormal_DNA_repair | 0.97108955 |
| 114 | MP0003631_nervous_system_phenotype | 0.96191246 |
| 115 | MP0001293_anophthalmia | 0.95719267 |
| 116 | MP0004142_abnormal_muscle_tone | 0.95380372 |
| 117 | MP0002254_reproductive_system_inflammat | 0.92740325 |
| 118 | MP0000747_muscle_weakness | 0.92349765 |
| 119 | MP0002557_abnormal_social/conspecific_i | 0.91025163 |
| 120 | MP0005379_endocrine/exocrine_gland_phen | 0.90974968 |
| 121 | MP0003633_abnormal_nervous_system | 0.90109975 |
| 122 | MP0003937_abnormal_limbs/digits/tail_de | 0.89413528 |
| 123 | MP0005365_abnormal_bile_salt | 0.89379495 |
| 124 | MP0001968_abnormal_touch/_nociception | 0.89236578 |
| 125 | MP0005389_reproductive_system_phenotype | 0.88580010 |
| 126 | MP0002909_abnormal_adrenal_gland | 0.88548543 |
| 127 | MP0004811_abnormal_neuron_physiology | 0.88534238 |
| 128 | MP0006138_congestive_heart_failure | 0.88230542 |
| 129 | MP0006054_spinal_hemorrhage | 0.87766837 |
| 130 | MP0002152_abnormal_brain_morphology | 0.87226255 |
| 131 | MP0001986_abnormal_taste_sensitivity | 0.87054226 |
| 132 | MP0002752_abnormal_somatic_nervous | 0.86652987 |
| 133 | MP0002796_impaired_skin_barrier | 0.86451632 |
| 134 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86161521 |
| 135 | MP0004087_abnormal_muscle_fiber | 0.84837580 |
| 136 | MP0002282_abnormal_trachea_morphology | 0.84156698 |
| 137 | MP0005174_abnormal_tail_pigmentation | 0.83758198 |
| 138 | MP0003938_abnormal_ear_development | 0.83001816 |
| 139 | MP0003045_fibrosis | 0.82458881 |
| 140 | MP0005084_abnormal_gallbladder_morpholo | 0.82425975 |
| 141 | MP0001177_atelectasis | 0.82155440 |
| 142 | MP0005248_abnormal_Harderian_gland | 0.82027084 |
| 143 | MP0002090_abnormal_vision | 0.81791049 |
| 144 | MP0001501_abnormal_sleep_pattern | 0.80053419 |
| 145 | MP0005187_abnormal_penis_morphology | 0.76952657 |
| 146 | MP0006276_abnormal_autonomic_nervous | 0.76555338 |
| 147 | MP0004147_increased_porphyrin_level | 0.76372726 |
| 148 | MP0002118_abnormal_lipid_homeostasis | 0.76137327 |
| 149 | MP0003868_abnormal_feces_composition | 0.75213026 |
| 150 | MP0005195_abnormal_posterior_eye | 0.74265901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 5.21049903 |
| 2 | Cerebral inclusion bodies (HP:0100314) | 4.25678787 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.23144231 |
| 4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.23144231 |
| 5 | Abnormality of the corticospinal tract (HP:0002492) | 4.16663090 |
| 6 | Sensory axonal neuropathy (HP:0003390) | 4.06768029 |
| 7 | Pancreatic cysts (HP:0001737) | 3.90156876 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 3.61945742 |
| 9 | Pancreatic fibrosis (HP:0100732) | 3.54449197 |
| 10 | Pheochromocytoma (HP:0002666) | 3.42813848 |
| 11 | Abnormality of the renal cortex (HP:0011035) | 3.36377577 |
| 12 | Spastic gait (HP:0002064) | 3.29991026 |
| 13 | Abnormality of midbrain morphology (HP:0002418) | 3.28300484 |
| 14 | Molar tooth sign on MRI (HP:0002419) | 3.28300484 |
| 15 | Nephronophthisis (HP:0000090) | 3.26756674 |
| 16 | Renal cortical cysts (HP:0000803) | 3.26321926 |
| 17 | True hermaphroditism (HP:0010459) | 3.15398576 |
| 18 | Termporal pattern (HP:0011008) | 3.14863148 |
| 19 | Insidious onset (HP:0003587) | 3.14863148 |
| 20 | Akinesia (HP:0002304) | 3.12187087 |
| 21 | Hyporeflexia of lower limbs (HP:0002600) | 3.09586291 |
| 22 | Intention tremor (HP:0002080) | 3.05959599 |
| 23 | Medial flaring of the eyebrow (HP:0010747) | 3.01379425 |
| 24 | Intestinal atresia (HP:0011100) | 2.93799609 |
| 25 | Intrahepatic cholestasis (HP:0001406) | 2.93607258 |
| 26 | Myokymia (HP:0002411) | 2.87487911 |
| 27 | Abnormality of the renal medulla (HP:0100957) | 2.87159891 |
| 28 | Dysmetria (HP:0001310) | 2.82504570 |
| 29 | Volvulus (HP:0002580) | 2.78268143 |
| 30 | Sudden death (HP:0001699) | 2.77430691 |
| 31 | Pendular nystagmus (HP:0012043) | 2.74100836 |
| 32 | Lower limb muscle weakness (HP:0007340) | 2.73587138 |
| 33 | Neuroendocrine neoplasm (HP:0100634) | 2.73129845 |
| 34 | Parakeratosis (HP:0001036) | 2.72848581 |
| 35 | Genital tract atresia (HP:0001827) | 2.70890430 |
| 36 | Congenital stationary night blindness (HP:0007642) | 2.69238082 |
| 37 | Onion bulb formation (HP:0003383) | 2.68616213 |
| 38 | Ankle clonus (HP:0011448) | 2.60053693 |
| 39 | Methylmalonic acidemia (HP:0002912) | 2.59692054 |
| 40 | Abolished electroretinogram (ERG) (HP:0000550) | 2.56334967 |
| 41 | Vaginal atresia (HP:0000148) | 2.55783201 |
| 42 | Gait imbalance (HP:0002141) | 2.55173531 |
| 43 | Hypothermia (HP:0002045) | 2.50462514 |
| 44 | Nephrogenic diabetes insipidus (HP:0009806) | 2.47122836 |
| 45 | Aplasia involving bones of the extremities (HP:0009825) | 2.46678867 |
| 46 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.46678867 |
| 47 | Aplasia of the phalanges of the hand (HP:0009802) | 2.46678867 |
| 48 | Megalencephaly (HP:0001355) | 2.46174481 |
| 49 | Gaze-evoked nystagmus (HP:0000640) | 2.45078599 |
| 50 | Epileptic encephalopathy (HP:0200134) | 2.38998320 |
| 51 | Atonic seizures (HP:0010819) | 2.36147719 |
| 52 | Deep venous thrombosis (HP:0002625) | 2.35820332 |
| 53 | Congenital primary aphakia (HP:0007707) | 2.35087394 |
| 54 | Febrile seizures (HP:0002373) | 2.34155491 |
| 55 | Abnormal auditory evoked potentials (HP:0006958) | 2.32254825 |
| 56 | Macroorchidism (HP:0000053) | 2.30231000 |
| 57 | Alacrima (HP:0000522) | 2.30192650 |
| 58 | Tubular atrophy (HP:0000092) | 2.29952136 |
| 59 | Lissencephaly (HP:0001339) | 2.29523043 |
| 60 | Oligodactyly (hands) (HP:0001180) | 2.29334553 |
| 61 | Broad-based gait (HP:0002136) | 2.26902784 |
| 62 | Abnormality of the labia minora (HP:0012880) | 2.26192179 |
| 63 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.21473244 |
| 64 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.21460672 |
| 65 | Generalized myoclonic seizures (HP:0002123) | 2.21418765 |
| 66 | Peripheral hypomyelination (HP:0007182) | 2.20744790 |
| 67 | Cystic liver disease (HP:0006706) | 2.20538381 |
| 68 | Excessive salivation (HP:0003781) | 2.20297367 |
| 69 | Drooling (HP:0002307) | 2.20297367 |
| 70 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.19683871 |
| 71 | Hyperventilation (HP:0002883) | 2.19302037 |
| 72 | Anophthalmia (HP:0000528) | 2.19051111 |
| 73 | Thickened helices (HP:0000391) | 2.18684632 |
| 74 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.17189775 |
| 75 | Morphological abnormality of the middle ear (HP:0008609) | 2.17071532 |
| 76 | Hamartoma of the eye (HP:0010568) | 2.16239985 |
| 77 | Focal seizures (HP:0007359) | 2.15577348 |
| 78 | Syncope (HP:0001279) | 2.14916504 |
| 79 | Difficulty running (HP:0009046) | 2.14612479 |
| 80 | Action tremor (HP:0002345) | 2.13837542 |
| 81 | Bilateral microphthalmos (HP:0007633) | 2.13426233 |
| 82 | Chronic hepatic failure (HP:0100626) | 2.11753755 |
| 83 | Epidermoid cyst (HP:0200040) | 2.10323797 |
| 84 | Optic nerve hypoplasia (HP:0000609) | 2.09927223 |
| 85 | Dysdiadochokinesis (HP:0002075) | 2.09010849 |
| 86 | Hypsarrhythmia (HP:0002521) | 2.08981674 |
| 87 | Cerebral hemorrhage (HP:0001342) | 2.08903737 |
| 88 | Methylmalonic aciduria (HP:0012120) | 2.07271531 |
| 89 | Attenuation of retinal blood vessels (HP:0007843) | 2.06825524 |
| 90 | EEG with generalized epileptiform discharges (HP:0011198) | 2.06812204 |
| 91 | Atrial fibrillation (HP:0005110) | 2.06067901 |
| 92 | Scanning speech (HP:0002168) | 2.05343086 |
| 93 | Agitation (HP:0000713) | 2.05205640 |
| 94 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.04971269 |
| 95 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.03860969 |
| 96 | Bifid tongue (HP:0010297) | 2.03780798 |
| 97 | Prolonged QT interval (HP:0001657) | 2.03518978 |
| 98 | Muscle fiber splitting (HP:0003555) | 2.02489997 |
| 99 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.01673152 |
| 100 | Right ventricular cardiomyopathy (HP:0011663) | 2.00596211 |
| 101 | Pachygyria (HP:0001302) | 2.00493361 |
| 102 | Keratoconus (HP:0000563) | 2.00409372 |
| 103 | Increased corneal curvature (HP:0100692) | 2.00409372 |
| 104 | Sclerocornea (HP:0000647) | 1.98771307 |
| 105 | Type II lissencephaly (HP:0007260) | 1.98531550 |
| 106 | Asplenia (HP:0001746) | 1.98524132 |
| 107 | Coronal craniosynostosis (HP:0004440) | 1.98256707 |
| 108 | Focal motor seizures (HP:0011153) | 1.97824013 |
| 109 | Short tibia (HP:0005736) | 1.97450315 |
| 110 | Epileptiform EEG discharges (HP:0011182) | 1.97414562 |
| 111 | Neoplasm of the adrenal cortex (HP:0100641) | 1.96281744 |
| 112 | Furrowed tongue (HP:0000221) | 1.96019163 |
| 113 | Relative macrocephaly (HP:0004482) | 1.95761377 |
| 114 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.94965791 |
| 115 | Polyphagia (HP:0002591) | 1.94342934 |
| 116 | Renal hypoplasia (HP:0000089) | 1.94311180 |
| 117 | Chorioretinal atrophy (HP:0000533) | 1.92720347 |
| 118 | Progressive inability to walk (HP:0002505) | 1.91482273 |
| 119 | Limb dystonia (HP:0002451) | 1.91386750 |
| 120 | Infantile muscular hypotonia (HP:0008947) | 1.91241964 |
| 121 | Decreased motor nerve conduction velocity (HP:0003431) | 1.90713837 |
| 122 | Primary atrial arrhythmia (HP:0001692) | 1.90588913 |
| 123 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.90276524 |
| 124 | Anencephaly (HP:0002323) | 1.89233587 |
| 125 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87832794 |
| 126 | Small hand (HP:0200055) | 1.87557967 |
| 127 | Large for gestational age (HP:0001520) | 1.87252317 |
| 128 | Spastic tetraparesis (HP:0001285) | 1.85643796 |
| 129 | Hemiparesis (HP:0001269) | 1.84767972 |
| 130 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.84142727 |
| 131 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84013776 |
| 132 | Decreased lacrimation (HP:0000633) | 1.83677852 |
| 133 | Specific learning disability (HP:0001328) | 1.83240151 |
| 134 | Abnormality of the parathyroid morphology (HP:0011766) | 1.83061245 |
| 135 | Blue irides (HP:0000635) | 1.82953554 |
| 136 | Hammertoe (HP:0001765) | 1.82595372 |
| 137 | Slow saccadic eye movements (HP:0000514) | 1.82414986 |
| 138 | Inability to walk (HP:0002540) | 1.81432024 |
| 139 | Postaxial foot polydactyly (HP:0001830) | 1.81390172 |
| 140 | Anteriorly placed anus (HP:0001545) | 1.80987368 |
| 141 | Postaxial hand polydactyly (HP:0001162) | 1.80158028 |
| 142 | Ketoacidosis (HP:0001993) | 1.79377266 |
| 143 | Hyperlipoproteinemia (HP:0010980) | 1.79145210 |
| 144 | Clonus (HP:0002169) | 1.79071530 |
| 145 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77975920 |
| 146 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.77246634 |
| 147 | Hypoplasia of the fovea (HP:0007750) | 1.77246634 |
| 148 | Abnormal drinking behavior (HP:0030082) | 1.76723337 |
| 149 | Polydipsia (HP:0001959) | 1.76723337 |
| 150 | Congenital hepatic fibrosis (HP:0002612) | 1.75378332 |
| 151 | Aqueductal stenosis (HP:0002410) | 1.74885643 |
| 152 | Progressive cerebellar ataxia (HP:0002073) | 1.74834836 |
| 153 | Spastic paraplegia (HP:0001258) | 1.74653421 |
| 154 | Bronchomalacia (HP:0002780) | 1.74071701 |
| 155 | Steppage gait (HP:0003376) | 1.72728134 |
| 156 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.72658379 |
| 157 | Narrow forehead (HP:0000341) | 1.72271344 |
| 158 | Generalized tonic-clonic seizures (HP:0002069) | 1.71912148 |
| 159 | Hypoglycemic seizures (HP:0002173) | 1.71749651 |
| 160 | Diminished movement (HP:0002374) | 1.70259265 |
| 161 | Paraparesis (HP:0002385) | 1.69322544 |
| 162 | Exercise-induced myalgia (HP:0003738) | 1.69206384 |
| 163 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.69050730 |
| 164 | Short 1st metacarpal (HP:0010034) | 1.69050730 |
| 165 | Postural instability (HP:0002172) | 1.68810968 |
| 166 | Clumsiness (HP:0002312) | 1.68197586 |
| 167 | Foot dorsiflexor weakness (HP:0009027) | 1.67866825 |
| 168 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.67811952 |
| 169 | Absent/shortened dynein arms (HP:0200106) | 1.67811952 |
| 170 | Abnormality of vitamin B metabolism (HP:0004340) | 1.67747374 |
| 171 | Preaxial hand polydactyly (HP:0001177) | 1.67489908 |
| 172 | Hyperglycinemia (HP:0002154) | 1.67111118 |
| 173 | Thyroid-stimulating hormone excess (HP:0002925) | 1.66880906 |
| 174 | Congenital sensorineural hearing impairment (HP:0008527) | 1.66878922 |
| 175 | Calf muscle hypertrophy (HP:0008981) | 1.66730738 |
| 176 | Congenital, generalized hypertrichosis (HP:0004540) | 1.66032532 |
| 177 | Supraventricular tachycardia (HP:0004755) | 1.65927924 |
| 178 | Cutaneous finger syndactyly (HP:0010554) | 1.65581213 |
| 179 | Progressive macrocephaly (HP:0004481) | 1.65472953 |
| 180 | Distal sensory impairment (HP:0002936) | 1.65399082 |
| 181 | Gastrointestinal atresia (HP:0002589) | 1.65315068 |
| 182 | Genetic anticipation (HP:0003743) | 1.64461302 |
| 183 | Decreased circulating renin level (HP:0003351) | 1.64456692 |
| 184 | Labial hypoplasia (HP:0000066) | 1.64295308 |
| 185 | Supraventricular arrhythmia (HP:0005115) | 1.63142063 |
| 186 | Decreased central vision (HP:0007663) | 1.63102239 |
| 187 | Urinary urgency (HP:0000012) | 1.62639441 |
| 188 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.62636010 |
| 189 | Abnormality of the foot musculature (HP:0001436) | 1.61097693 |
| 190 | Paraplegia (HP:0010550) | 1.60939520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.14750303 |
| 2 | PRPF4B | 3.93495891 |
| 3 | MARK1 | 3.71354196 |
| 4 | STK39 | 3.55035677 |
| 5 | WNK3 | 3.15488239 |
| 6 | TRIM28 | 2.84672442 |
| 7 | LATS1 | 2.84033993 |
| 8 | MAP4K2 | 2.52056084 |
| 9 | OXSR1 | 2.35440316 |
| 10 | BCR | 2.12642895 |
| 11 | GRK1 | 2.11698877 |
| 12 | PKN1 | 2.07777294 |
| 13 | ACVR1B | 2.02534289 |
| 14 | PHKG1 | 2.00522695 |
| 15 | PHKG2 | 2.00522695 |
| 16 | PAK6 | 1.90586128 |
| 17 | MET | 1.87931332 |
| 18 | NTRK1 | 1.83819142 |
| 19 | ADRBK2 | 1.83034803 |
| 20 | FGFR2 | 1.80352507 |
| 21 | PAK3 | 1.79011093 |
| 22 | ERBB3 | 1.70679142 |
| 23 | EPHB1 | 1.70614687 |
| 24 | ICK | 1.67180146 |
| 25 | EPHA4 | 1.64066337 |
| 26 | WNK1 | 1.55305746 |
| 27 | WNK4 | 1.53952833 |
| 28 | MAP3K9 | 1.50108526 |
| 29 | PLK2 | 1.42697178 |
| 30 | NTRK2 | 1.42572023 |
| 31 | PINK1 | 1.42245099 |
| 32 | ERBB4 | 1.39974439 |
| 33 | MKNK2 | 1.37098345 |
| 34 | INSRR | 1.35771967 |
| 35 | STK16 | 1.34936488 |
| 36 | CSNK1G2 | 1.32935846 |
| 37 | EIF2AK3 | 1.31852635 |
| 38 | CSNK1A1L | 1.30046834 |
| 39 | UHMK1 | 1.28228016 |
| 40 | CASK | 1.27688654 |
| 41 | MAP3K4 | 1.23543670 |
| 42 | CSNK1G3 | 1.22619759 |
| 43 | NTRK3 | 1.20535665 |
| 44 | ZAK | 1.19399811 |
| 45 | DYRK2 | 1.16795274 |
| 46 | LIMK1 | 1.13347049 |
| 47 | TNIK | 1.08982559 |
| 48 | SGK223 | 1.08288773 |
| 49 | SGK494 | 1.08288773 |
| 50 | NEK6 | 1.07755890 |
| 51 | CSNK1G1 | 1.07100817 |
| 52 | MST4 | 1.05756549 |
| 53 | NUAK1 | 1.05266028 |
| 54 | MARK2 | 1.04935415 |
| 55 | ROCK2 | 1.03786347 |
| 56 | TYRO3 | 1.03287621 |
| 57 | CDK5 | 1.03216430 |
| 58 | PLK3 | 1.02300954 |
| 59 | LATS2 | 1.01200740 |
| 60 | PRKCG | 1.00867398 |
| 61 | CAMK2D | 0.98341894 |
| 62 | MAP3K2 | 0.95597953 |
| 63 | CAMK2B | 0.94842053 |
| 64 | PLK4 | 0.94097635 |
| 65 | CAMK2A | 0.92477952 |
| 66 | PNCK | 0.92367225 |
| 67 | PIK3CA | 0.90000510 |
| 68 | EPHB2 | 0.89622153 |
| 69 | MAPK13 | 0.86689289 |
| 70 | CAMK1G | 0.84697501 |
| 71 | KSR2 | 0.83922152 |
| 72 | RET | 0.83823431 |
| 73 | PRKCE | 0.81931585 |
| 74 | FGR | 0.81770162 |
| 75 | MINK1 | 0.80901355 |
| 76 | DMPK | 0.80899231 |
| 77 | BRSK2 | 0.80465129 |
| 78 | TRPM7 | 0.78727205 |
| 79 | PRKCH | 0.77899064 |
| 80 | CAMKK2 | 0.77766810 |
| 81 | TGFBR1 | 0.77709788 |
| 82 | STK11 | 0.75676734 |
| 83 | ROCK1 | 0.74300897 |
| 84 | LMTK2 | 0.73237820 |
| 85 | KSR1 | 0.71741855 |
| 86 | CDC42BPA | 0.71526840 |
| 87 | SIK1 | 0.68933038 |
| 88 | TLK1 | 0.68929454 |
| 89 | ADRBK1 | 0.67980898 |
| 90 | TIE1 | 0.67365967 |
| 91 | CDK19 | 0.67165323 |
| 92 | SRPK1 | 0.66825873 |
| 93 | CAMK2G | 0.66616497 |
| 94 | MKNK1 | 0.65875768 |
| 95 | PRKD1 | 0.65701844 |
| 96 | MAP2K4 | 0.65597551 |
| 97 | VRK1 | 0.64638614 |
| 98 | OBSCN | 0.62372120 |
| 99 | CDK14 | 0.62335581 |
| 100 | MAP2K7 | 0.61597094 |
| 101 | PDPK1 | 0.61382753 |
| 102 | MAPK15 | 0.60442268 |
| 103 | FER | 0.60089349 |
| 104 | HIPK2 | 0.59855530 |
| 105 | CCNB1 | 0.59023029 |
| 106 | DAPK2 | 0.58734619 |
| 107 | SGK1 | 0.58488799 |
| 108 | STK38L | 0.58100477 |
| 109 | PRKD3 | 0.57446422 |
| 110 | PDGFRB | 0.57332177 |
| 111 | STK3 | 0.57302360 |
| 112 | CSNK1D | 0.56002472 |
| 113 | DYRK3 | 0.55501929 |
| 114 | DYRK1A | 0.55017893 |
| 115 | ERBB2 | 0.54825623 |
| 116 | DDR2 | 0.54073148 |
| 117 | GRK5 | 0.53927074 |
| 118 | BMPR1B | 0.53865129 |
| 119 | WEE1 | 0.52480662 |
| 120 | PRKAA1 | 0.52425915 |
| 121 | PRKG1 | 0.52386633 |
| 122 | PRKCZ | 0.52145850 |
| 123 | PLK1 | 0.51668106 |
| 124 | CDK15 | 0.51611372 |
| 125 | MAPKAPK5 | 0.50913110 |
| 126 | PTK2 | 0.49995180 |
| 127 | PRKCQ | 0.49090910 |
| 128 | SIK3 | 0.48355133 |
| 129 | TEC | 0.48326044 |
| 130 | CDK18 | 0.48326026 |
| 131 | FYN | 0.48271267 |
| 132 | MUSK | 0.47292668 |
| 133 | CSNK1A1 | 0.46736274 |
| 134 | GSK3A | 0.46231713 |
| 135 | SGK2 | 0.45398705 |
| 136 | SGK3 | 0.44290229 |
| 137 | EPHA3 | 0.43971382 |
| 138 | TAOK3 | 0.43965245 |
| 139 | FLT3 | 0.43933818 |
| 140 | PRKACA | 0.41351043 |
| 141 | MAP3K7 | 0.40735236 |
| 142 | ABL1 | 0.38903143 |
| 143 | BCKDK | 0.37891779 |
| 144 | PTK2B | 0.37714623 |
| 145 | NLK | 0.37468808 |
| 146 | ATM | 0.36825108 |
| 147 | PRKCI | 0.36321803 |
| 148 | MAP2K6 | 0.35104478 |
| 149 | NME1 | 0.34931265 |
| 150 | AKT3 | 0.33949892 |
| 151 | CSNK1E | 0.32356711 |
| 152 | PRKACB | 0.32056241 |
| 153 | CAMK1 | 0.31617136 |
| 154 | CDK3 | 0.29719750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 2.54190573 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.40422869 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.14692072 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.03341706 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94376708 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.90175256 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.83645687 |
| 8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.82420587 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.82354404 |
| 10 | RNA degradation_Homo sapiens_hsa03018 | 1.71058781 |
| 11 | Axon guidance_Homo sapiens_hsa04360 | 1.68028213 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.62060042 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55756380 |
| 14 | Basal transcription factors_Homo sapiens_hsa03022 | 1.49146982 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.44137824 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.40335223 |
| 17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.40002658 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.38907582 |
| 19 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.38731333 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37925149 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37850062 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36149554 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33295387 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.29710840 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26931082 |
| 26 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.22590440 |
| 27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.20043442 |
| 28 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.19992711 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.17793200 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.17672679 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.16711505 |
| 32 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.16491247 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16309678 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.15844270 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.14631893 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.14405022 |
| 37 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.13207680 |
| 38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.11988390 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.10677676 |
| 40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.10606552 |
| 41 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.10243214 |
| 42 | Insulin secretion_Homo sapiens_hsa04911 | 1.09041459 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.07874737 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 1.07688192 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.07063137 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.06875947 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06574169 |
| 48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.06092384 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02434656 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02237964 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.99628454 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99616655 |
| 53 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.99267407 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99232364 |
| 55 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.98786412 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97619514 |
| 57 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97436211 |
| 58 | Salivary secretion_Homo sapiens_hsa04970 | 0.97358293 |
| 59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96973738 |
| 60 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.96959232 |
| 61 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.95847120 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95233952 |
| 63 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94471097 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92792140 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92408304 |
| 66 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.91284912 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 0.90285477 |
| 68 | Taste transduction_Homo sapiens_hsa04742 | 0.89271658 |
| 69 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.89117676 |
| 70 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.88559492 |
| 71 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.88273461 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85258612 |
| 73 | Long-term depression_Homo sapiens_hsa04730 | 0.85236004 |
| 74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.84309923 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 0.84029945 |
| 76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.84018249 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83858931 |
| 78 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82114180 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.81996488 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 0.81966032 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.81630246 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.81182475 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80368978 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78904068 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77635764 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.77231865 |
| 87 | Olfactory transduction_Homo sapiens_hsa04740 | 0.76925218 |
| 88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76925144 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.76702714 |
| 90 | Gap junction_Homo sapiens_hsa04540 | 0.74881354 |
| 91 | Long-term potentiation_Homo sapiens_hsa04720 | 0.74092724 |
| 92 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74024537 |
| 93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72333454 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71562037 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71079794 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70880908 |
| 97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70436063 |
| 98 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68399267 |
| 99 | Melanogenesis_Homo sapiens_hsa04916 | 0.68011055 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67025004 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66900168 |
| 102 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.66322116 |
| 103 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66083663 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64846435 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63824981 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63525111 |
| 107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62642442 |
| 108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62559837 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61162195 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59417405 |
| 111 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59315890 |
| 112 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.58318463 |
| 113 | RNA polymerase_Homo sapiens_hsa03020 | 0.56938023 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.54937708 |
| 115 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.53840084 |
| 116 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53766376 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.53566509 |
| 118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52809303 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52582143 |
| 120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.51370714 |
| 121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51188167 |
| 122 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50370584 |
| 123 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50052566 |
| 124 | Phototransduction_Homo sapiens_hsa04744 | 0.50017353 |
| 125 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49757341 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49630484 |
| 127 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48956621 |
| 128 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48777225 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.47991177 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45868939 |
| 131 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45840095 |
| 132 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45632553 |
| 133 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45631245 |
| 134 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45492449 |
| 135 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44780764 |
| 136 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.44655756 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44571981 |
| 138 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.42571980 |
| 139 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41845891 |
| 140 | Purine metabolism_Homo sapiens_hsa00230 | 0.41834265 |
| 141 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35362358 |

